Exporter cette référence

Sandborn W, Feagan BG, Gasink C, et al (2016) A Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Ustekinumab Maintenance Therapy in Moderate–Severe Crohn's Disease Patients: Results From IM-UNITI. Gastroenterology AGA Abstract 768

Colon Rectum, 10 4 (2016) 260-263
DOI: https://doi.org/10.1007/s11725-016-0667-x